News and Events

News

Helsinn and the Scientific Centre of Monaco Sign Collaboration Agreement

January 30th, 2018

Investigating the role of pharmacological inhibitors in kidney cancer

Read article

Helsinn Group and MEI Pharma Announce that Pracinostat has Received Orphan Drug ...

January 11th, 2018

Lugano, Switzerland, and San Diego, USA, January 11, 2018 – Helsinn, a Swiss pharmaceutical group focused on building quality cancer care products, an...

Read article

A call for action to patient entrepreneurs in the area of cancer to compete at t...

January 9th, 2018

Lyfebulb Helsinn Innovation Award5

The Award recognizes Patient Entrepreneurs’ Innovative Efforts and Ideas for cancer and cancer supportive care using drugs, medical devices, consumer ...

Read article

Helsinn to honor Anna Braglia Endowed Young Investigator Award recipient at Hels...

January 8th, 2018

Dr. Sarah A. Buckley to be recognized as the inaugural Anna Braglia Endowed Young Investigator Award in Cancer Supportive Care recipient during the JP...

Read article

Helsinn Group supports Satellite Symposium at 10th International Conference on C...

December 5th, 2017

Helsinn, a Swiss pharmaceutical group focused on building quality cancer care products, today announces that it is supporting a satellite symposium ho...

Read article

Events

59th ASH ANNUAL MEETING AND EXPOSITION

  • 9th December 2017 - 12th December 2017
Full event info

40th SAN ANTONIO BREAST CANCER SYMPOSIUM

  • 5th December 2017 - 9th December 2017
  • San Antonio
Full event info

Chemotherapy Foundation Symposium - 2017

Helsinn will be present in New York City at the 35th annual edition of the Chemotherapy Foundation Symposium.

  • 8th November 2017 - 10th November 2017
  • New York City
Full event info